tradmap

HIMS Hims & Hers Health, Inc.

$25.22 -8.85%

Data as of close

Healthcare · Services-Offices & Clinics Of Doctors Of Medicine

Hims & Hers Health, Inc. (HIMS) is a healthcare company in the Services-Offices & Clinics Of Doctors Of Medicine industry, with a market capitalization of $5.9 billion. Shares last traded at $25.22, 47.9% below their 52-week high. Over the past year the stock is down 43.8%. Net profit margin is -5.5%, above the peer median of -6.2%. Revenue grew 59.0% year over year.

Market Cap
$5.9B
Shares Out
233.3M
EPS (TTM)
-$0.63
P/E (TTM)*
—
P/S Ratio
2.28
P/B Ratio
18.16
Dividend / Share
—
Dividend Yield
—
52-Week High
$48.42
52-Week Low
$13.75
Volume (venue)
411,369
Avg Vol (3m, venue)
420,707.444

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-8.56%
1M
-12.97%
3M
-21.19%
6M
-7.01%
YTD
-22.18%
1Y
-43.81%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
36.78
SMA (50)
$28.85
SMA (200)
$26.93
Price vs SMA50
-12.58%
Price vs SMA200
-6.35%
ATR (14)
$1.86

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$2.6B
Net Income
-$142M
Gross Margin
68.4%
Operating Margin
-6.0%
Net Margin
-5.5%
Return on Equity
-43.8%
Return on Assets
-3.9%
Current Ratio
0.93
Debt / Equity
10.20
Revenue Growth (YoY)
+59.0%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 -$0.37 2026-08-10
Q1 2026 -$0.40 2026-05-11
Q4 2025 (derived) $0.08 2026-02-23
FY 2025 $0.51 2026-02-23
Q3 2025 $0.06 2025-11-03
Q2 2025 $0.17 2025-08-04

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Services-Offices & Clinics Of Doctors Of Medicine peers

HIMS vs 11 industry peers (Services-Offices & Clinics Of Doctors Of Medicine), by market cap. Data as of close

P/S vs peers
2.28 / 0.94 med
+142% premium
Net margin vs peers
-5.5% / -6.2% med
above median
1–11 of 11
HIMSHims & Hers Health, Inc.$5.9B—2.28-5.5%-8.85%
TDOCTeladoc Health, Inc.$1.6B—0.64-6.3%+1.41%
STLNStarling Oncology, Inc.$637M—1.08-6.2%-4.21%
SBCSBC Medical Group Holdings Inc$546M11.143.1228.0%+0.66%
AIRSAirsculpt Technologies, Inc.$120M—0.80-7.8%-5.11%
LFMDLifemd, Inc.$111M551.520.670.1%+0.00%
WSTNWestin Acquisition Corp$81M91.04——+0.00%
BMGLBasel Medical Group Ltd$8M———+1.48%
CCMConcord Medical Services Holdings Ltd———-20.2%+4.94%
AUNAAuna S.A.————-0.22%
SBCWWSBC Medical Group Holdings Inc————+31.31%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.